Comparing remimazolam and propofol for anesthesia in major surgeries

REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry (REPOSE-2): A Multicenter Randomized Controlled Trial

Phase 4 Interventional Nanfang Hospital, Southern Medical University · NCT05728775

This study is testing whether a new anesthesia drug called remimazolam can help older patients undergoing major surgeries recover better and spend more days out of the hospital compared to the standard drug, propofol.

Quick facts

PhasePhase 4
Study typeInterventional
Enrollment7188 (estimated)
Ages45 Years and up
SexAll
SponsorNanfang Hospital, Southern Medical University Academic / other
Locations44 sites (Hefei, Anhui and 43 other locations)
Trial IDNCT05728775 on ClinicalTrials.gov

What this trial studies

This randomized controlled trial aims to evaluate the effectiveness of total intravenous anesthesia using remimazolam compared to propofol in patients at moderate-to-high risk undergoing major elective noncardiac surgeries. The primary focus is to determine if remimazolam can lead to more days alive and out of the hospital by postoperative day 30. Eligible participants include those aged 45 and older with specific health conditions that increase surgical risk. The study will assess outcomes related to anesthesia management and postoperative recovery.

Who should consider this trial

Good fit: Ideal candidates are patients aged 45 and older who are undergoing elective major surgery and have at least one risk factor for complications.

Not a fit: Patients undergoing low-risk or minor surgeries, or those with severe hepatic or renal dysfunction, may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could improve postoperative recovery and reduce complications for patients undergoing major surgeries.

How similar studies have performed: Previous studies have shown promising results with remimazolam in anesthesia, suggesting potential benefits over traditional agents like propofol.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥45 years;
* Undergoing elective major surgery under general anesthesia (expected surgery time \>2 h, expected length of postoperative stay \>2 d);
* Fulfilling ≥1 of the following criteria:

  1. history of coronary artery disease;
  2. history of stroke;
  3. history of congestive heart failure;
  4. preoperative NT-proBNP \>200 pg/mL or BNP\>92 pg/mL;
  5. age ≥70 years;
  6. diabetes requiring medical treatment;
  7. ASA status 3 or 4;
  8. history of chronic kidney disease (preoperative sCr \>133 μmol/L or 1.5 mg/dL);
  9. history of peripheral arterial disease;
  10. preoperative serum albumin \<30 g/L;
  11. preoperative hemoglobin \<100 g/L.

Exclusion Criteria:

* Undergoing organ transplantation, cardiac, craniocerebral, burn or interventional operations;
* Low risk or minor surgery
* End-stage renal disease requiring renal-replacement therapy;
* Hepatic dysfunction (Child B or C);
* Previous liver or kidney transplantation;
* Previous allergy to general anesthetics;
* Unable to receive bispectral index monitoring;
* ASA score ≥5;
* Exposure to general anesthesia in prior 30 days or anticipated re-exposure to general anesthesia within 30 days after surgery;
* Need for prolonged airway protection or mechanical ventilatory support after surgery;
* Current participation in another interventional study;
* Previous participation in this study;
* Pregnant or breastfeeding women.

Where this trial is running

Hefei, Anhui and 43 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions AnesthesiaSurgery-Complications
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.